New Horizons Medical is a Massachusetts-based startup that specializes in providing mental health and substance abuse treatment services. Founded in 2009, the company offers a range of services including medication management, psychotherapy, and integrated lab testing. Initially established as a private physician group dedicated to the safe prescription of buprenorphine (Suboxone) for patients recovering from opiate dependence, the company has since expanded to provide compassionate care to individuals regardless of their addiction history. The startup operates in the Healthcare industry and is headquartered in the United States. As of now, there is no publicly available information about their last investment or the investors involved. New Horizons Medical's commitment to addressing the critical issues of mental health and substance use aligns with the growing focus on these areas in the healthcare industry. With its unique approach and specialized services, the company presents an attractive opportunity for potential venture capital investors seeking to support innovative solutions in healthcare.
There is no investment information
No recent news or press coverage available for New Horizons Medical.